- Home
- LFCR vs NEWT Comparison
LFCR vs NEWT Comparison
Compare LFCR & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$8.30
Company Overview
Basic Information| Metric | LFCR | NEWT |
|---|---|---|
| Founded | 1986 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.0M | 300.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LFCR | NEWT |
|---|---|---|
| Price | $8.30 | $11.53 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 3 |
| Target Price | $6.00 | ★ $13.00 |
| AVG Volume (30 Days) | 172.3K | ★ 260.8K |
| Earning Date | 01-02-2026 | 10-29-2025 |
| Dividend Yield | N/A | ★ 6.68% |
| EPS Growth | N/A | ★ 32.88 |
| EPS | N/A | ★ 2.23 |
| Revenue | $128,867,000.00 | ★ $380,364,000.00 |
| Revenue This Year | $2.80 | N/A |
| Revenue Next Year | $11.51 | $12.56 |
| P/E Ratio | ★ N/A | $5.09 |
| Revenue Growth | 0.47 | ★ 20.21 |
| 52 Week Low | $4.76 | $9.12 |
| 52 Week High | $8.85 | $13.74 |
Technical Indicators
Market Signals| Indicator | LFCR | NEWT |
|---|---|---|
| Relative Strength Index (RSI) | 59.43 | 54.26 |
| Support Level | $7.85 | $11.69 |
| Resistance Level | $8.77 | $12.38 |
| Average True Range (ATR) | 0.36 | 0.32 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 63.64 | 29.17 |
Price Performance
Historical Comparison LFCR
NEWT
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.